136 related articles for article (PubMed ID: 34467896)
21. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
[TBL] [Abstract][Full Text] [Related]
22. Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression.
Young MJ; Chen YC; Wang SA; Chang HP; Yang WB; Lee CC; Liu CY; Tseng YL; Wang YC; Sun HS; Chang WC; Hung JJ
J Biomed Sci; 2022 Jan; 29(1):3. PubMed ID: 35034634
[TBL] [Abstract][Full Text] [Related]
23. MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.
Patnaik S; Mallick R; Kannisto E; Sharma R; Bshara W; Yendamuri S; Dhillon SS
J Thorac Oncol; 2015 Mar; 10(3):446-53. PubMed ID: 25695220
[TBL] [Abstract][Full Text] [Related]
24. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Liu C; Kelnar K; Liu B; Chen X; Calhoun-Davis T; Li H; Patrawala L; Yan H; Jeter C; Honorio S; Wiggins JF; Bader AG; Fagin R; Brown D; Tang DG
Nat Med; 2011 Feb; 17(2):211-5. PubMed ID: 21240262
[TBL] [Abstract][Full Text] [Related]
25. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.
Li W; Pan T; Jiang W; Zhao H
Biomed Pharmacother; 2020 Sep; 129():110217. PubMed ID: 32559619
[TBL] [Abstract][Full Text] [Related]
26. Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis.
Liu C; Rokavec M; Huang Z; Hermeking H
Cell Death Differ; 2023 Jul; 30(7):1771-1785. PubMed ID: 37210578
[TBL] [Abstract][Full Text] [Related]
27. miR-34b inhibits the migration/invasion and promotes apoptosis of non-small-cell lung cancer cells by YAF2.
Zhuang XF; Zhao LX; Guo SP; Wei S; Zhai JF; Zhou QH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2038-2046. PubMed ID: 30915747
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
29. MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells.
Wen H; Liu Z; Tang J; Bu L
Aging (Albany NY); 2021 Sep; 13(17):21435-21450. PubMed ID: 34500436
[TBL] [Abstract][Full Text] [Related]
30. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175
[TBL] [Abstract][Full Text] [Related]
31. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
32. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
33. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
Wang R; Dong HX; Zeng J; Pan J; Jin XY
J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359
[TBL] [Abstract][Full Text] [Related]
34. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
Feng H; Ge F; Du L; Zhang Z; Liu D
J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
[TBL] [Abstract][Full Text] [Related]
35. miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1.
Nie J; Ge X; Geng Y; Cao H; Zhu W; Jiao Y; Wu J; Zhou J; Cao J
Oncol Rep; 2015 Jul; 34(1):311-7. PubMed ID: 25954903
[TBL] [Abstract][Full Text] [Related]
36. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
Jiao P; Hou J; Yao M; Wu J; Ren G
Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
[TBL] [Abstract][Full Text] [Related]
37. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
38. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
39. miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14.
Jia LF; Wei SB; Mitchelson K; Gao Y; Zheng YF; Meng Z; Gan YH; Yu GY
PLoS One; 2014; 9(9):e108435. PubMed ID: 25268950
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]